Gvoke Vialdx Injection, Solution
Product Images NDC 0517-2901

Product Visual Gallery

This gallery contains 54 technical images submitted to the FDA as part of the official labeling for Gvoke Vialdx (NDC 0517-2901). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Regent, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Its Molecular Formula Is C153h225n43o49s With The Following Structure: (Gvoke Vialdx Glucagon Injection 1)

This appears to be a sequence of amino acids represented by their three-letter codes, ending with the termination codon "COOH". The sequence starts with "NH;", indicating the N-terminus. The sequence consists of 29 amino acids in total.*

FDA Label Image

Ifua-sideb-f2 (Gvoke Vialdx Glucagon Injection 10)

FDA Label Image

Ifua-sideb-f3 (Gvoke Vialdx Glucagon Injection 11)

FDA Label Image

Ifua-sideb-f4 (Gvoke Vialdx Glucagon Injection 12)

FDA Label Image

Ifua-sideb-f5 (Gvoke Vialdx Glucagon Injection 13)

Not available.*

FDA Label Image

Ifua-sideb-f6 (Gvoke Vialdx Glucagon Injection 14)

This text provides a simple and direct instruction to expose the skin at the injection site. It implies a clear and important step to ensure that the injection is administered correctly and safely.*

FDA Label Image

Ifua-sideb-f7 (Gvoke Vialdx Glucagon Injection 15)

This text provides instructions for pushing and holding down a button for 5 seconds.*

FDA Label Image

Ifua-sideb-f8 (Gvoke Vialdx Glucagon Injection 16)

FDA Label Image

Ifua-sideb-f9 (Gvoke Vialdx Glucagon Injection 17)

This is a description of a medical device, likely a needle guard that can be locked over the needle to prevent accidents or injuries. The text suggests that it allows easy and safe removal from the skin.*

FDA Label Image

Ifua-sideb-f10 (Gvoke Vialdx Glucagon Injection 18)

FDA Label Image

Ifua-sideb-f11 (Gvoke Vialdx Glucagon Injection 19)

FDA Label Image

Figure 1 (Gvoke Vialdx Glucagon Injection 2)

FDA Label Image

Pfs Pouch 1 mg (Gvoke Vialdx Glucagon Injection 20)

This is a set of instructions for preparing and administering Gvoke PFS (glucagon injection) to treat low blood sugar emergencies. The text details how to tear open the pouch, choose an injection site (lower abdomen, outer thighs, or outer upper arm), pinch the skin, insert the needle at a 90-degree angle, push the plunger down to inject, and call emergency medical help. It also emphasizes not removing air bubbles from the syringe.*

FDA Label Image

Pfs Image (Gvoke Vialdx Glucagon Injection 21)

Description: This product consists of a NeedleCap, Needle, Finger Flange, Plunger, and a Viewing Window. It is used in conjunction with a Syringe Body for medical or laboratory purposes. The components provide support and functionality for safe and efficient use of the syringe.*

FDA Label Image

Ifub Slideb-f1 (Gvoke Vialdx Glucagon Injection 22)

FDA Label Image

Ifub Slideb-f2 (Gvoke Vialdx Glucagon Injection 23)

FDA Label Image

Ifub Slideb-f3 (Gvoke Vialdx Glucagon Injection 24)

FDA Label Image

Ifub Slideb-f4 (Gvoke Vialdx Glucagon Injection 25)

FDA Label Image

Ifub Slideb-f5 (Gvoke Vialdx Glucagon Injection 26)

This text indicates a medical instruction to expose the skin at the injection site. This step is commonly done before administering an injection to ensure proper placement and access to the injection site.*

FDA Label Image

Ifub Slideb-f6 (Gvoke Vialdx Glucagon Injection 27)

FDA Label Image

Ifub Slideb-f7 (Gvoke Vialdx Glucagon Injection 28)

FDA Label Image

Ifub Slideb-f8 (Gvoke Vialdx Glucagon Injection 29)

FDA Label Image

Figure 2 (Gvoke Vialdx Glucagon Injection 3)

This text provides information on Mean Plasma Glucose (mg/dL) for different age groups. It includes data for ages 2 to under 6 years, ages 6 to under 12 years, and ages 12 to under 18 years. The values are given in milligrams per deciliter (mg/dL). Additionally, the information seems to be related to a time-dependent analysis judging by the mention of "Time (minutes)".*

FDA Label Image

Ifub Slideb-f9 (Gvoke Vialdx Glucagon Injection 30)

FDA Label Image

Ifub Slideb-f10 (Gvoke Vialdx Glucagon Injection 31)

FDA Label Image

Ifub Slideb-f11 (Gvoke Vialdx Glucagon Injection 32)

This text is not available.*

FDA Label Image

Ifub Slideb-f12 (Gvoke Vialdx Glucagon Injection 33)

FDA Label Image

Full Vial And Syringe (Gvoke Vialdx Glucagon Injection 34)

This is a description of medical supplies including a Blue Cap, Syringe Needle, Plunger Body, Needle Cap, Vial, and Syringe. It indicates that each Gvoke vial and syringe should be used only once and then discarded for safety reasons.*

FDA Label Image

Gvoke Kit Figure A (Gvoke Vialdx Glucagon Injection 35)

FDA Label Image

Gvoke Kit Figure B (Gvoke Vialdx Glucagon Injection 36)

FDA Label Image

Gvoke Kit Figure C (Gvoke Vialdx Glucagon Injection 37)

FDA Label Image

Gvoke Kit Figure D (Gvoke Vialdx Glucagon Injection 38)

FDA Label Image

Gvoke Kit Figure E (Gvoke Vialdx Glucagon Injection 39)

FDA Label Image

Figure 3 (Gvoke Vialdx Glucagon Injection 4)

FDA Label Image

Gvoke Kit Figure F (Gvoke Vialdx Glucagon Injection 40)

FDA Label Image

Gvoke Kit Figure G (Gvoke Vialdx Glucagon Injection 41)

FDA Label Image

Gvoke Kit Figure H (Gvoke Vialdx Glucagon Injection 42)

FDA Label Image

Gvoke Kit Figure I (Gvoke Vialdx Glucagon Injection 43)

This text appears to provide information about dosages for medication. The pediatric dose is 0.1 ml, while the adult dose is 0.2 ml. It seems that the medication is indicated by "TS."*

FDA Label Image

Gvoke Kit Figure J (Gvoke Vialdx Glucagon Injection 44)

FDA Label Image

Gvoke Kit Figure K (Gvoke Vialdx Glucagon Injection 45)

This text refers to a medical instruction regarding exposing the skin at the injection site, which is a common practice in healthcare settings when administering injections or vaccinations.*

FDA Label Image

Gvoke Kit Figure L (Gvoke Vialdx Glucagon Injection 46)

FDA Label Image

Gvoke Kit Figure M (Gvoke Vialdx Glucagon Injection 47)

FDA Label Image

Gvoke Kit Figure N (Gvoke Vialdx Glucagon Injection 48)

FDA Label Image

Gvoke Kit Figure O (Gvoke Vialdx Glucagon Injection 49)

FDA Label Image

Figure 4 (Gvoke Vialdx Glucagon Injection 5)

FDA Label Image

Gvoke Kit Figure P (Gvoke Vialdx Glucagon Injection 50)

FDA Label Image

Gvoke Kit Figure Q (Gvoke Vialdx Glucagon Injection 51)

FDA Label Image

Vial Label (Gvoke Vialdx Glucagon Injection 52)

This text contains information about a product called Gvoke VialDx™, which has an NDC code of 0517-2901-01. It is indicated for intravenous injection after dilution for diagnostic use only. The product contains 1 mg per 0.2 mL of glucagon injection. It is advised to discard any unused portion of the product. The manufacturer is American Regent located in Shirley, NY 11967. The document contains revision details as RN1220-A Rev.02/2025.*

FDA Label Image

Carton (Single Pack)

This text provides important information about a medication called Gvoke VialDx™, which contains a sterile solution for delivery. Each vial contains 0.2 mL and should be stored at a temperature between 15°C to 30°C. The medication should not be refrigerated or exposed to extreme temperatures. Additionally, it mentions the dosage information for intravenous injection after dilution. The text also includes details about the manufacturer, American Regent, Inc., and advice on discarding any unused portions of the vial.*

FDA Label Image

Carton (10 Pack)

Not available.*

FDA Label Image

Ai Pouch 1 mg (Gvoke Vialdx Glucagon Injection 6)

This text provides instructions for using the Gvoke HypoPen during low blood sugar emergencies. It outlines three main steps: 1. Prepare, 2. Inject, and 3. Assist. The user is instructed to tear open the pouch, choose an injection site, push down on the skin to inject, hold down for 5 seconds, and turn the patient on their side. After the injection, the used pen should be placed in a safe location until it can be disposed of in an FDA-cleared sharps container. The text also references the red cap, needle end, and a window that turns red to indicate when to call for emergency medical help.*

FDA Label Image

Ai Pouch 0.5 mg (Gvoke Vialdx Glucagon Injection 7)

FDA Label Image

Ai Image (Gvoke Vialdx Glucagon Injection 8)

FDA Label Image

Ifua-sideb-f1 (Gvoke Vialdx Glucagon Injection 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.